This inventor holds 36 USPTO granted patents and 19 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Panmira Pharmaceuticals, LLC, Amira Pharmaceuticals, Inc., Merck + Co., Inc.. Active years: 2006-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2006 - 2013)
- Encinitas, CA (US) (2011 - 2023)
Company Filing History:
14 out of 23 
8 out of 23 
6 out of 4,770 
Years Active: 2006-2023
Areas of Expertise:
Title: Brian Andrew Stearns: Innovator in Cancer Treatment
Introduction
Brian Andrew Stearns, based in Encinitas, California, is a prolific inventor with a remarkable portfolio of 36 patents. His work primarily focuses on the development of pharmaceutical compounds that hold the potential for significant advancements in cancer treatment and viral infections.
Latest Patents
Stearns's latest inventions include innovative triazolone compounds and their pharmaceutical applications. These compounds, characterized by Formula I and their pharmaceutically acceptable salts, demonstrate efficacy in treating a variety of cancers, including prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, and melanoma. Moreover, his inventions encompass pharmaceutical compositions that consist of therapeutically effective amounts of these compounds and methods for treating associated cancers. His research also extends to developing therapeutic strategies utilizing selective PPARα antagonists and addressing viral infections such as HCV and HIV.
Career Highlights
Throughout his career, Brian Stearns has contributed his expertise to notable organizations like Panmira Pharmaceuticals and Amira Pharmaceuticals. His innovative approach and commitment to advancing medical science have made a substantial impact in the field of pharmacology and oncology.
Collaborations
Stearns has collaborated with recognized professionals in the industry, including John Howard Hutchinson and Jeannie M Arruda. Their combined efforts exemplify the strength of teamwork in pushing the boundaries of medical research and drug discovery.
Conclusion
Brian Andrew Stearns is a distinguished inventor whose work on triazolone compounds is paving the way for new therapeutic options in the fight against cancer and viral diseases. His innovative contributions continue to inspire advancements in pharmaceutical science, demonstrating the profound impact of dedicated inventors in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile